Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 11, 2002 - Issue 6
Submit an article Journal homepage
225
Views
94
CrossRef citations to date
0
Altmetric
Miscellaneous

Dopamine receptor agonists for treating prolactinomas

Annamaria Colao Department of Molecular and Clinical Endocrinology and Oncology, ‘Federico II’ University of Naples, Italy
,
Carolina di Somma Department of Molecular and Clinical Endocrinology and Oncology, ‘Federico II’ University of Naples, Italy
,
Gaetano Lombardi Department of Molecular and Clinical Endocrinology and Oncology, ‘Federico II’ University of Naples, Italy
,
Rosario Pivonello Department of Molecular and Clinical Endocrinology and Oncology, ‘Federico II’ University of Naples, Italy
&
Antonella di Sarno Department of Molecular and Clinical Endocrinology and Oncology, ‘Federico II’ University of Naples, Italy
Pages 787-800 | Published online: 24 Feb 2005

Citations (94)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Adam Mamelak. (2022) Surgery as a first-line option for prolactinomas. Expert Review of Endocrinology & Metabolism 17:6, pages 485-498.
Read now
Martin J. Rutkowski & Manish K. Aghi. (2018) Medical versus surgical treatment of prolactinomas: an analysis of treatment outcomes. Expert Review of Endocrinology & Metabolism 13:1, pages 25-33.
Read now
Ping Li, Songbai Gui, Lei Cao, Hua Gao, Jiwei Bai, Chuzhong Li & Yazhuo Zhang. (2016) Use of micro-positron emission tomography with 18F-fallypride to measure the levels of dopamine receptor-D2 and 18F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats. OncoTargets and Therapy 9, pages 2057-2068.
Read now
Renata S. Auriemma, Ludovica F. S. Grasso, Rosario Pivonello & Annamaria Colao. (2016) The safety of treatments for prolactinomas. Expert Opinion on Drug Safety 15:4, pages 503-512.
Read now
Joost van der Hoek, Steven WJ Lamberts & Leo J Hofland. (2010) The somatostatin receptor subtype 5 in neuroendocrine tumours. Expert Opinion on Investigational Drugs 19:3, pages 385-399.
Read now
Jana Ježková & Josef Marek. (2009) Diagnosis and treatment of prolactinomas. Expert Review of Endocrinology & Metabolism 4:2, pages 135-142.
Read now

Articles from other publishers (88)

James G. Pfaus, Radu A. Antonie, Peter I. Dosa & Suck Won Kim. (2023) Effects of cabergoline and dimethylcabergoline on the sexual behavior of male rats. Psychopharmacology.
Crossref
Len KohODOD, Megan E. McChesneyODOD & Chad E. GosnellODOD. (2023) Pituitary Adenoma Hidden by Comorbid Cataract. Optometric Clinical Practice 2:5, pages 63-73.
Crossref
Renata S Auriemma, Rosa Pirchio, Claudia Pivonello, Francesco Garifalos, Annamaria Colao & Rosario Pivonello. (2023) Approach to the Patient With Prolactinoma. The Journal of Clinical Endocrinology & Metabolism 108:9, pages 2400-2423.
Crossref
Tamara L. Wexler & Gabrielle Page‐Wilson. (2023) Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies. British Journal of Clinical Pharmacology 89:4, pages 1304-1317.
Crossref
Savas Karatas, Yalcin Hacioglu & Taskin Rakicioglu. (2022) Prolactinoma - which patients react favorably to cabergoline medication?. Endocrine Regulations 56:4, pages 279-283.
Crossref
Philippe Chanson & Dominique Maiter. 2022. The Pituitary. The Pituitary 495 543 .
Kartik Yadav, Sharjeel Shaikh & Gianluca Tamagno. 2022. Pituitary Adenomas. Pituitary Adenomas 173 193 .
Karan J. Yagnik, Dana Erickson, Irina Bancos, John L. D. Atkinson, Garret Choby, Maria Peris-Celda & Jamie J. Van Gompel. (2021) Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis. Pituitary 24:6, pages 978-988.
Crossref
Samridhi Banskota & David C. Adamson. (2021) Pituitary Adenomas: From Diagnosis to Therapeutics. Biomedicines 9:5, pages 494.
Crossref
Lakshmi P. Menon & Wedad Rahman. (2021) Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma. Journal of Investigative Medicine High Impact Case Reports 9, pages 232470962110297.
Crossref
Elle Vermeulen, Jean D’Haens, Tadeusz Stadnik, David Unuane, Kurt Barbe, Vera Van Velthoven & Sven Gläsker. (2020) Predictors of dopamine agonist resistance in prolactinoma patients. BMC Endocrine Disorders 20:1.
Crossref
Marta Araujo-Castro, Ainhoa Abad López, Javier Aller Pardo, Laura Kanaan Kanaan & Nuria Palacios García. (2020) Phenotype and resistance patterns of 10 resistant prolactinomas. Endocrinología, Diabetes y Nutrición 67:3, pages 194-204.
Crossref
Marta Araujo-Castro, Ainhoa Abad López, Javier Aller Pardo, Laura Kanaan Kanaan & Nuria Palacios García. (2020) Phenotype and resistance patterns of 10 resistant prolactinomas. Endocrinología, Diabetes y Nutrición (English ed.) 67:3, pages 194-204.
Crossref
Mustafa Taşdelen & Şenay Durmaz Ceylan. (2019) An interesting hormon and interesting disease: hyperprolactinemia and prolactinoma. Ortadoğu Tıp Dergisi 11:4, pages 561-576.
Crossref
Sema Ciftci Dogansen, Ugur Cikrikcili, Gonca Oruk, Nilufer Ozdemir Kutbay, Seher Tanrikulu, Zeliha Hekimsoy, Aysa Hadzalic, Suheyla Gorar, Tulay Omma, Meral Mert, Gulhan Akbaba, Gulsah Yenidunya Yalin, Fahri Bayram, Mine Ozkan & Sema Yarman. (2019) Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study. The Journal of Clinical Endocrinology & Metabolism 104:7, pages 2527-2534.
Crossref
Philippe Chanson & Dominique Maiter. (2019) The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Practice & Research Clinical Endocrinology & Metabolism 33:2, pages 101290.
Crossref
Nicholas A. Tritos & Anne Klibanski. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology 58 74.e8 .
Qianquan Ma, Jun Su, Ying Li, Jiaxing Wang, Wenyong Long, Mei Luo & Qing Liu. (2018) The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 9.
Crossref
Yen-Ho Lai & Ping-Hong Lai. (2018) An Unusual Cause of Tension Pneumoventricle. The Journal of Emergency Medicine 55:2, pages 257-259.
Crossref
Ernesto Sosa-Eroza, Etual Espinosa, Claudia Ramírez-Rentería, Victoria Mendoza, Rocío Arreola & Moises Mercado. (2018) Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR. Endocrine 61:2, pages 343-348.
Crossref
Hai Yan Huang, Shao Jian Lin, Wei Guo Zhao & Zhe Bao Wu. (2018) Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review. Metabolic Brain Disease 33:3, pages 969-976.
Crossref
Miao Yun Xia, Xiao Hui Lou, Shao Jian Lin & Zhe Bao Wu. (2017) Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis. Endocrine 59:1, pages 50-61.
Crossref
Lian Duan, Hua Yan, Minqiang Huang, Yuhui Zhang & Feng Gu. (2017) An Economic Analysis of Bromocriptine Versus Trans-Sphenoidal Surgery for the Treatment of Prolactinoma. Journal of Craniofacial Surgery 28:4, pages 1046-1051.
Crossref
Philippe Chanson & Dominique Maiter. 2017. The Pituitary. The Pituitary 467 514 .
Rosario Pivonello, Ciro Salzano, Mariano Galdiero & Annamaria Colao. 2017. Male Hypogonadism. Male Hypogonadism 169 186 .
Rosario Pivonello, Marlijn Waaijers, Johan M. Kros, Claudia Pivonello, Cristina de Angelis, Alessia Cozzolino, Annamaria Colao, Steven W.J. Lamberts & Leo J. Hofland. (2016) Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland. Endocrine.
Crossref
Abdallah Adra, Mazen Yousef El Zibdeh, Abdul Malek Mohammed Abdul Malek, Amir H. Hamrahian, Amr Mohamed Salaheldin Abdelhamid, Annamaria Colao, Elie Anastasiades, Essam Moustafa Aboul Fetooh Ahmed, Jihad Ibrahim Ezzeddine, Mahmoud Ibrahim Abd El Sattar, Suleiman Tawfiq Dabit, Wadih Ghanameh, Navid Nedjatian & Faysal El-Kak. (2016) Differential diagnosis and management of abnormal uterine bleeding due to hyperprolactinemia. Middle East Fertility Society Journal 21:3, pages 137-147.
Crossref
Sema Ciftci Dogansen, Ozlem Soyluk Selcukbiricik, Seher Tanrikulu & Sema Yarman. (2016) Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?. Pituitary 19:3, pages 303-310.
Crossref
Wenya Linda Bi, Ian F. Dunn & Edward R. LawsJr.Jr.. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric 275 290.e4 .
Timothy R. Smith, M. Maher Hulou, Kevin T. Huang, Abdulkerim Gokoglu, David J. Cote, Whitney W. Woodmansee & Edward R. LawsJr.Jr.. (2015) Current indications for the surgical treatment of prolactinomas. Journal of Clinical Neuroscience 22:11, pages 1785-1791.
Crossref
Rosario Pivonello, Monica De Leo, Alessia Cozzolino & Annamaria Colao. (2015) The Treatment of Cushing's Disease. Endocrine Reviews 36:4, pages 385-486.
Crossref
Agnieszka Stefańska, Alicja Hubalewska-Dydejczyk, Agata Jabrocka-Hybel & Anna Sowa-Staszczak. 2015. Somatostatin Analogues. Somatostatin Analogues 282 290 .
Jason S. Cheng, Ryan Salinas, Annette Molinaro, Edward F. Chang, Sandeep Kunwar, Lewis Blevins & Manish K. Aghi. (2015) A predictive algorithm for evaluating elevated serum prolactin in patients with a sellar mass. Journal of Clinical Neuroscience 22:1, pages 155-160.
Crossref
Youwei Wang, Junyang Li, Mamatemin Tohti, Yuebing Hu, Sheng Wang, Wanchun Li, Zhenfeng Lu & Chiyuan Ma. (2014) The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Mark E. Molitch. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology 45 65.e11 .
Ashu Rastogi, Anil Bhansali, Pinaki Dutta, Paramjit Singh, Rajesh Vijaivergiya, Vaishali Gupta, Naresh Sachdeva, Sanjay Kumar Bhadada & Rama Walia. (2013) A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinoma. Clinical Endocrinology 79:3, pages 409-415.
Crossref
Luis G. Sobrinho. 2013. Pituitary Disorders. Pituitary Disorders 138 145 .
S. Baldari, F. Ferraù, C. Alafaci, A. Herberg, F. Granata, V. Militano, F. M. Salpietro, F. Trimarchi & S. Cannavò. (2012) First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. Pituitary 15:S1, pages 57-60.
Crossref
Michael C. Oh, Sandeep Kunwar, Lewis Blevins & Manish K. Aghi. (2012) Medical Versus Surgical Management of Prolactinomas. Neurosurgery Clinics of North America 23:4, pages 669-678.
Crossref
Michael C. Oh, Tarik Tihan, Sandeep Kunwar, Lewis Blevins & Manish K. Aghi. (2012) Clinical Management of Pituitary Carcinomas. Neurosurgery Clinics of North America 23:4, pages 595-606.
Crossref
A. P. Athanasoulia, C. Sievers, M. Ising, A. C. Brockhaus, A. Yassouridis, G. K. Stalla & M. Uhr. (2012) Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas. European Journal of Endocrinology 167:3, pages 327-335.
Crossref
Kiren Yacqub-Usman, Alan Richardson, Cuong V. Duong, Richard N. Clayton & William E. Farrell. (2012) The pituitary tumour epigenome: aberrations and prospects for targeted therapy. Nature Reviews Endocrinology 8:8, pages 486-494.
Crossref
Thomas Cuny, Amira Mohamed, Thomas Graillon, Catherine Roche, Céline Defilles, Anne-Laure Germanetti, Bettina Couderc, Dominique Figarella-Branger, Alain Enjalbert, Anne Barlier & Alexandru Saveanu. (2012) Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: Impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. Molecular and Cellular Endocrinology 355:1, pages 106-113.
Crossref
Haitham Hamoda, Yakoub Khalaf & Paul Carroll. (2012) Hyperprolactinaemia and female reproductive function: what does the evidence say?. The Obstetrician & Gynaecologist 14:2, pages 81-86.
Crossref
Valentina Martena, Roberta Censi, Ela Hoti, Ledjan Malaj & Piera Di Martino. (2011) Physicochemical characterization of nicergoline and cabergoline in its amorphous state. Journal of Thermal Analysis and Calorimetry 108:1, pages 323-332.
Crossref
Paula Lustoza Gomes, Vania S Nunes, Álvaro N Atallah & Edina MK da Silva. (2012) Dopamine agonists for hyperprolactinaemia. Cochrane Database of Systematic Reviews.
Crossref
James K. Liu, Mark D. Krieger, Arun P. Amar, William T. Couldwell & Martin H. Weiss. 2012. Schmidek and Sweet Operative Neurosurgical Techniques. Schmidek and Sweet Operative Neurosurgical Techniques 221 227 .
Nestoras Mathioudakis & Roberto Salvatori. 2012. Schmidek and Sweet Operative Neurosurgical Techniques. Schmidek and Sweet Operative Neurosurgical Techniques 203 214 .
Francisco Delgado-Rosas, Raúl Gómez, Hortensia Ferrero, Francisco Gaytan, Juan Garcia-Velasco, Carlos Simón & Antonio Pellicer. (2011) The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. REPRODUCTION 142:5, pages 745-755.
Crossref
Vania dos Santos Nunes, Regina El Dib, César Luiz Boguszewski & Célia Regina Nogueira. (2011) Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis. Pituitary 14:3, pages 259-265.
Crossref
Michael C. Oh & Manish K. Aghi. (2011) Dopamine agonist–resistant prolactinomas. Journal of Neurosurgery 114:5, pages 1369-1379.
Crossref
Annamaria Colao & Silvia Savastano. (2011) Medical treatment of prolactinomas. Nature Reviews Endocrinology 7:5, pages 267-278.
Crossref
V. Vasilev, A. F. Daly, L. Vroonen, S. Zacharieva & A. Beckers. (2011) Resistant prolactinomas. Journal of Endocrinological Investigation 34:4, pages 312-316.
Crossref
Raul Gómez, Antonio Abad, Francisco Delgado, Silvia Tamarit, Carlos Simón & Antonio Pellicer. (2011) Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia. Fertility and Sterility 95:3, pages 882-888.e1.
Crossref
Haneen Al-Azzawi, Kiren Yacqub-Usman, Alan Richardson, Leo J. Hofland, Richard N. Clayton & William E. Farrell. (2011) Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis. Endocrinology 152:2, pages 364-373.
Crossref
Igor J. Barani, Penny K. Sneed & Michael W. McDermott. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery 2582 2600 .
Ariane Godbout, Marcos Manavela, Karina Danilowicz, Hugues Beauregard, Oscar Domingo Bruno & André Lacroix. (2010) Cabergoline monotherapy in the long-term treatment of Cushing's disease. European Journal of Endocrinology 163:5, pages 709-716.
Crossref
Christopher S. Platta, Christopher MacKay & James S. Welsh. (2010) Pituitary Adenoma. American Journal of Clinical Oncology 33:4, pages 408-419.
Crossref
Yavuz Aydin, Alev Atis, Semih Kaleli, Seyfettin Uludağ & Nimet Goker. (2010) Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study. European Journal of Obstetrics & Gynecology and Reproductive Biology 150:2, pages 203-206.
Crossref
Maja Ponikvar-Svet & Joel F. Liebman. (2009) Interplay of thermochemistry and Structural Chemistry, the journal (volume 17, 2006) and the discipline. Structural Chemistry 20:6, pages 1019-1037.
Crossref
Annamaria Colao. (2009) The prolactinoma. Best Practice & Research Clinical Endocrinology & Metabolism 23:5, pages 575-596.
Crossref
Raffaele Capasso, Gabriella Aviello, Francesco Capasso, Francesco Savino, Angelo A. Izzo, Francesca Lembo & Francesca Borrelli. (2009) Silymarin BIO-C®, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats. Phytomedicine 16:9, pages 839-844.
Crossref
Annamaria Colao, Rosario Pivonello, Carolina Di Somma, Silvia Savastano, Ludovica F. S. Grasso & Gaetano Lombardi. (2008) Medical therapy of pituitary adenomas: Effects on tumor shrinkage. Reviews in Endocrine and Metabolic Disorders 10:2, pages 111-123.
Crossref
Nina F. Schor. (2009) Pharmacotherapy for adults with tumors of the central nervous system. Pharmacology & Therapeutics 121:3, pages 253-264.
Crossref
Mark E. Molitch. 2009. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology 57 78 .
Mark Molitch. 2008. Textbook of Periconceptional Medicine. Textbook of Periconceptional Medicine 179 189 .
Mark E Molitch. 2008. Textbook of Periconceptional Medicine. Textbook of Periconceptional Medicine 179 190 .
F. Bogazzi, S. Buralli, L. Manetti, V. Raffaelli, T. Cigni, M. Lombardi, F. Boresi, S. Taddei, A. Salvetti & E. Martino. (2008) Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia. International Journal of Clinical Practice 62:12, pages 1864-1869.
Crossref
V.A. Castillo, N.V. Gómez, J.C. Lalia, M.F. Cabrera Blatter & J.D. García. (2008) Cushing’s disease in dogs: Cabergoline treatment. Research in Veterinary Science 85:1, pages 26-34.
Crossref
V.A.S.H. Dalm, L.J. Hofland & S.W.J. Lamberts. (2008) Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field. Molecular and Cellular Endocrinology 286:1-2, pages 262-277.
Crossref
J Kreutzer, R Buslei, H Wallaschofski, B Hofmann, C Nimsky, R Fahlbusch & M Buchfelder. (2007) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. European Journal of Endocrinology 158:1, pages 11-18.
Crossref
Jay Jagannathan, Adam S. Kanter, Jason P. Sheehan, John A. JaneJr.Jr. & Edward R. LawsJr.Jr.. (2007) Benign Brain Tumors: Sellar/Parasellar Tumors. Neurologic Clinics 25:4, pages 1231-1249.
Crossref
J. van der Hoek, S. W J Lamberts & L. J Hofland. (2007) Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas. European Journal of Endocrinology 156:suppl_1, pages S45-S51.
Crossref
Rosario Pivonello, Diego Ferone, Wouter W. de Herder, Antongiulio Faggiano, Lisa Bodei, Ronald R. de Krijger, Gaetano Lombardi, Annamaria Colao, Steven W. J. Lamberts & Leo J. Hofland. (2007) Dopamine Receptor Expression and Function in Corticotroph Ectopic Tumors. The Journal of Clinical Endocrinology & Metabolism 92:1, pages 65-69.
Crossref
Günther Stockhammer, Theresa Kindl, Herwig Kostron, Thomas Auberger & Armin Muigg. 2007. Neurologische Erkrankungen in der Schwangerschaft. Neurologische Erkrankungen in der Schwangerschaft 139 181 .
Sandra Mutiara, Haruhiko Kanasaki, Takashi Harada & Kohji Miyazaki. (2006) Dopamine D2 receptor expression and regulation of gonadotropin α-subunit gene in clonal gonadotroph LβT2 cells. Molecular and Cellular Endocrinology 259:1-2, pages 22-29.
Crossref
Mary P. GillamMark E. MolitchGaetano Lombardi & Annamaria Colao. (2006) Advances in the Treatment of Prolactinomas. Endocrine Reviews 27:5, pages 485-534.
Crossref
David A. Gorelick & Jeffery N. Wilkins. (2006) Bromocriptine treatment for cocaine addiction: Association with plasma prolactin levels. Drug and Alcohol Dependence 81:2, pages 189-195.
Crossref
Alexandr Jegorov, Ladislav Cvak, Roman Bednář, Jan Čejka, Michal Hušák, Bohumil Kratochvíl & Ivana Císařová. (2006) Structures of cabergoline anhydrate form II and novel cabergoline solvates. Structural Chemistry 17:1, pages 131-137.
Crossref
Rosario de Miguel, José Ramos, Maribel Cebeira, Mariluz Hernández & Javier Fernández-Ruiz. 2005. Endocannabinoids. Endocannabinoids.
M. G. Kadieva, É. T. Oganesyan & S. Kh. Mutsueva. (2005) Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 2: dopamine receptors and their agonists. Pharmaceutical Chemistry Journal 39:10, pages 520-532.
Crossref
M. Manno, F. Tomei, E. Marchesan & V. Adamo. (2005) Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?. European Journal of Obstetrics & Gynecology and Reproductive Biology 122:1, pages 127-128.
Crossref
Jason P. Sheehan, Ajay Niranjan, Jonas M. Sheehan, John A. Jane, Edward R. Laws, Douglas Kondziolka, John Flickinger, Alex M. Landolt, Jay S. Loeffler & L. Dade Lunsford. (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. Journal of Neurosurgery 102:4, pages 678-691.
Crossref
James K. Liu & William T. Couldwell. (2004) Contemporary management of prolactinomas. Neurosurgical Focus 16:4, pages 1-11.
Crossref
Annamaria Colao, Giovanni Vitale, Michele De Rosa & Gaetano Lombardi. 2004. Male Hypogonadism. Male Hypogonadism 139 158 .
Kulvinder Kaur, Mandeep Singh & S.P.S. Virk. (2003) Prolactinomas in infertility. Reviews in Gynaecological Practice 3:4, pages 180-187.
Crossref
Giovanni Vitale, Antonella Di Sarno, Francesca Rota, Gaetano Lombardi & Annamaria Colao. (2003) When can we stop cabergoline treatment in prolactinomas?. Current Opinion in Endocrinology & Diabetes 10:4, pages 259-264.
Crossref
A. Colao & G. Lombardi. 2003. Endoscopic Endonasal Transsphenoidal Surgery. Endoscopic Endonasal Transsphenoidal Surgery 41 59 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.